FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — Pfizer’s coronavirus vaccine provides surprisingly robust protection against the highly infectious Delta variant of COVID-19 — but only if you’ve gotten both doses. Fresh data out of England shows that two doses of the messenger RNA (mRNA) vaccine is 88% effective in protectingContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — A proposed $26 billion settlement on opioid-related lawsuits has been reached with four large drug companies, a group of state attorneys general announced Wednesday. If enough states sign on to the deal with the country’s three major drug distributors — Cardinal Health, AmerisourceBergenContinue Reading